 | • レポートコード：GIR201100233 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、急性呼吸窮迫症候群治療の世界市場を調査対象にし、急性呼吸窮迫症候群治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（メチルプレドニゾロン、ヒドロコルチゾン、注入用子牛肺サーファクタント、その他）、用途別分析（入院、外来）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Therabron Therapeutics, Inc.、FirstString Research, Inc.、Histocell S.L.、Serendex Pharmaceuticals A/S、Faron Pharmaceuticals Oy、Silence Therapeutics Plc、Phylogica Limited、Athersys, Inc.、Altor BioScience Corporation、GlaxoSmithKline Plc ・メーカー別販売量、売上、市場シェア ・急性呼吸窮迫症候群治療の地域別市場分析 ・急性呼吸窮迫症候群治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・急性呼吸窮迫症候群治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・急性呼吸窮迫症候群治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・急性呼吸窮迫症候群治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・急性呼吸窮迫症候群治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・急性呼吸窮迫症候群治療の種類別市場規模2015-2020：メチルプレドニゾロン、ヒドロコルチゾン、注入用子牛肺サーファクタント、その他 ・急性呼吸窮迫症候群治療の用途別市場規模2015-2020：入院、外来 ・急性呼吸窮迫症候群治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Acute Respiratory Distress Syndrome Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Acute Respiratory Distress Syndrome Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Acute Respiratory Distress Syndrome Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Acute Respiratory Distress Syndrome Therapeutics market has been segmented into
Methylprednisolone
Hydrocortisone
Calf Pulmonary Surfactant for Injection
Others
By Application, Acute Respiratory Distress Syndrome Therapeutics has been segmented into:
In-Patient
Out-Patient
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Respiratory Distress Syndrome Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Respiratory Distress Syndrome Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Respiratory Distress Syndrome Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Acute Respiratory Distress Syndrome Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Acute Respiratory Distress Syndrome Therapeutics Market Share Analysis
Acute Respiratory Distress Syndrome Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Respiratory Distress Syndrome Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Respiratory Distress Syndrome Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Acute Respiratory Distress Syndrome Therapeutics are:
Therabron Therapeutics, Inc.
FirstString Research, Inc.
Histocell S.L.
Serendex Pharmaceuticals A/S
Faron Pharmaceuticals Oy
Silence Therapeutics Plc
Phylogica Limited
Athersys, Inc.
Altor BioScience Corporation
GlaxoSmithKline Plc
Among other players domestic and global, Acute Respiratory Distress Syndrome Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Acute Respiratory Distress Syndrome Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Acute Respiratory Distress Syndrome Therapeutics, with price, sales, revenue and global market share of Acute Respiratory Distress Syndrome Therapeutics in 2018 and 2019.
Chapter 3, the Acute Respiratory Distress Syndrome Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Acute Respiratory Distress Syndrome Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Acute Respiratory Distress Syndrome Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Acute Respiratory Distress Syndrome Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Acute Respiratory Distress Syndrome Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Methylprednisolone
1.2.3 Hydrocortisone
1.2.4 Calf Pulmonary Surfactant for Injection
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 In-Patient
1.3.3 Out-Patient
1.4 Overview of Global Acute Respiratory Distress Syndrome Therapeutics Market
1.4.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Therabron Therapeutics, Inc.
2.1.1 Therabron Therapeutics, Inc. Details
2.1.2 Therabron Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Therabron Therapeutics, Inc. SWOT Analysis
2.1.4 Therabron Therapeutics, Inc. Product and Services
2.1.5 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 FirstString Research, Inc.
2.2.1 FirstString Research, Inc. Details
2.2.2 FirstString Research, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 FirstString Research, Inc. SWOT Analysis
2.2.4 FirstString Research, Inc. Product and Services
2.2.5 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Histocell S.L.
2.3.1 Histocell S.L. Details
2.3.2 Histocell S.L. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Histocell S.L. SWOT Analysis
2.3.4 Histocell S.L. Product and Services
2.3.5 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Serendex Pharmaceuticals A/S
2.4.1 Serendex Pharmaceuticals A/S Details
2.4.2 Serendex Pharmaceuticals A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Serendex Pharmaceuticals A/S SWOT Analysis
2.4.4 Serendex Pharmaceuticals A/S Product and Services
2.4.5 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Faron Pharmaceuticals Oy
2.5.1 Faron Pharmaceuticals Oy Details
2.5.2 Faron Pharmaceuticals Oy Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Faron Pharmaceuticals Oy SWOT Analysis
2.5.4 Faron Pharmaceuticals Oy Product and Services
2.5.5 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Silence Therapeutics Plc
2.6.1 Silence Therapeutics Plc Details
2.6.2 Silence Therapeutics Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Silence Therapeutics Plc SWOT Analysis
2.6.4 Silence Therapeutics Plc Product and Services
2.6.5 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Phylogica Limited
2.7.1 Phylogica Limited Details
2.7.2 Phylogica Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Phylogica Limited SWOT Analysis
2.7.4 Phylogica Limited Product and Services
2.7.5 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Athersys, Inc.
2.8.1 Athersys, Inc. Details
2.8.2 Athersys, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Athersys, Inc. SWOT Analysis
2.8.4 Athersys, Inc. Product and Services
2.8.5 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Altor BioScience Corporation
2.9.1 Altor BioScience Corporation Details
2.9.2 Altor BioScience Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Altor BioScience Corporation SWOT Analysis
2.9.4 Altor BioScience Corporation Product and Services
2.9.5 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline Plc
2.10.1 GlaxoSmithKline Plc Details
2.10.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline Plc SWOT Analysis
2.10.4 GlaxoSmithKline Plc Product and Services
2.10.5 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Acute Respiratory Distress Syndrome Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 Acute Respiratory Distress Syndrome Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
6.4 France Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
7.5 India Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global Acute Respiratory Distress Syndrome Therapeutics Price by Type (2015-2020)
11 Global Acute Respiratory Distress Syndrome Therapeutics Market Segment by Application
11.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global Acute Respiratory Distress Syndrome Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 Acute Respiratory Distress Syndrome Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025)
12.2.2 Europe Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025)
12.2.4 South America Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025)
12.3 Acute Respiratory Distress Syndrome Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global Acute Respiratory Distress Syndrome Therapeutics Market Share Forecast by Type (2021-2025)
12.4 Acute Respiratory Distress Syndrome Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global Acute Respiratory Distress Syndrome Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Acute Respiratory Distress Syndrome Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acute Respiratory Distress Syndrome Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acute Respiratory Distress Syndrome Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Therabron Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 9. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 10. Therabron Therapeutics, Inc. SWOT Analysis
Table 11. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 12. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. FirstString Research, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 15. FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 16. FirstString Research, Inc. SWOT Analysis
Table 17. FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 18. FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Histocell S.L. Basic Information, Manufacturing Base and Competitors
Table 20. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 21. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 22. Histocell S.L. SWOT Analysis
Table 23. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 24. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Serendex Pharmaceuticals A/S Basic Information, Manufacturing Base and Competitors
Table 26. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 27. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 28. Serendex Pharmaceuticals A/S SWOT Analysis
Table 29. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 30. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Faron Pharmaceuticals Oy Basic Information, Manufacturing Base and Competitors
Table 32. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 33. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 34. Faron Pharmaceuticals Oy SWOT Analysis
Table 35. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 36. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Silence Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 38. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 39. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 40. Silence Therapeutics Plc SWOT Analysis
Table 41. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 42. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Phylogica Limited Basic Information, Manufacturing Base and Competitors
Table 44. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 45. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 46. Phylogica Limited SWOT Analysis
Table 47. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 48. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Athersys, Inc. Basic Information, Manufacturing Base and Competitors
Table 50. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 51. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 52. Athersys, Inc. SWOT Analysis
Table 53. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 54. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Altor BioScience Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 57. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 58. Altor BioScience Corporation SWOT Analysis
Table 59. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 60. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Major Business
Table 63. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Total Revenue (USD Million) (2018-2019)
Table 64. GlaxoSmithKline Plc SWOT Analysis
Table 65. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product and Services
Table 66. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Acute Respiratory Distress Syndrome Therapeutics Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Acute Respiratory Distress Syndrome Therapeutics Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Regions (2015-2020)
Table 71. Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Acute Respiratory Distress Syndrome Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Countries (2015-2020)
Table 74. North America Acute Respiratory Distress Syndrome Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries (2015-2020)
Table 76. Europe Acute Respiratory Distress Syndrome Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Countries (2015-2020)
Table 78. Europe Acute Respiratory Distress Syndrome Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Acute Respiratory Distress Syndrome Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Countries (2015-2020)
Table 84. South America Acute Respiratory Distress Syndrome Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries (2015-2020)
Table 90. Global Acute Respiratory Distress Syndrome Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 91. Global Acute Respiratory Distress Syndrome Therapeutics Sales Share by Type (2015-2020)
Table 92. Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Type (2015-2020) (USD Million)
Table 93. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Share by Type (2015-2020)
Table 94. Global Acute Respiratory Distress Syndrome Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 95. Global Acute Respiratory Distress Syndrome Therapeutics Sales Share by Application (2015-2020)
Table 96. Global Acute Respiratory Distress Syndrome Therapeutics Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Acute Respiratory Distress Syndrome Therapeutics Market Share Forecast by Regions (2021-2025)
Table 98. Global Acute Respiratory Distress Syndrome Therapeutics Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Acute Respiratory Distress Syndrome Therapeutics Market Share Forecast by Type (2021-2025)
Table 100. Global Acute Respiratory Distress Syndrome Therapeutics Sales Forecast by Application (2021-2025)
Table 101. Global Acute Respiratory Distress Syndrome Therapeutics Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Acute Respiratory Distress Syndrome Therapeutics Picture
Figure 2. Global Sales Market Share of Acute Respiratory Distress Syndrome Therapeutics by Type in 2019
Figure 3. Methylprednisolone Picture
Figure 4. Hydrocortisone Picture
Figure 5. Calf Pulmonary Surfactant for Injection Picture
Figure 6. Others Picture
Figure 7. Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Application in 2018
Figure 8. In-Patient Picture
Figure 9. Out-Patient Picture
Figure 10. Global Acute Respiratory Distress Syndrome Therapeutics Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Acute Respiratory Distress Syndrome Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Manufacturer in 2019
Figure 31. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Acute Respiratory Distress Syndrome Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Acute Respiratory Distress Syndrome Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 36. Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 38. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Regions in 2018
Figure 39. North America Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
Figure 40. Europe Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
Figure 42. South America Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020)
Figure 44. North America Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Countries (2015-2020)
Figure 46. North America Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Countries in 2018
Figure 47. North America Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries in 2018
Figure 49. United States Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Canada Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Mexico Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Europe Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries in 2019
Figure 55. Germany Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. UK Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. France Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Regions 2019
Figure 63. China Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Korea Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. India Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. South America Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Countries in 2019
Figure 70. South America Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries in 2019
Figure 71. Brazil Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Argentina Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Egypt Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Turkey Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. South Africa Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Global Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate (2021-2025) (K Pcs)
Figure 82. Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 84. Europe Sales Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 85. Asia-Pacific Sales Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 86. South America Sales Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 87. Middle East & Africa Sales Acute Respiratory Distress Syndrome Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
プラダー・ウィリ症候群治療の世界市場 2020年 Market Overview The global Prader-Willi Syndrome Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prader-Wil…- レット症候群治療の世界市場 2020年 Market Overview The global Rett Syndrome Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rett Syndrome Ther…
- ドラベット症候群治療薬の世界市場 2020年 Market Overview The global Dravet Syndrome Thereapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dravet Syndrome…
- アッシャー症候群治療薬の世界市場 2020年 Market Overview The global Usher Syndrome Threapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Usher Syndrome Th…
- レノックス・ガストー症候群治療薬の世界市場 2020年 Market Overview The global Lennox-Gastaut Syndrome Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lennox-Gastaut S…